Your browser doesn't support javascript.
loading
An Alternatively Spliced p62 Isoform Confers Resistance to Chemotherapy in Breast Cancer.
Guo, Qianying; Wang, Hao; Duan, Jiahao; Luo, Wenwu; Zhao, Rongrong; Shen, Yuting; Wang, Bijun; Tao, Siqi; Sun, Yi; Ye, Qian; Bi, Xiaomin; Yuan, Hui; Wu, Qiang; Lobie, Peter E; Zhu, Tao; Tan, Sheng; Huang, Xing; Wu, Zhengsheng.
  • Guo Q; Department of Pathology, School of Basic Medical Sciences, Anhui Medical University, Hefei, Anhui, P.R. China.
  • Wang H; Department of Pathology, School of Basic Medical Sciences, Anhui Medical University, Hefei, Anhui, P.R. China.
  • Duan J; Department of Pathology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, P.R. China.
  • Luo W; Department of Pathology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, P.R. China.
  • Zhao R; Department of Pathology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, P.R. China.
  • Shen Y; Department of Pathology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, P.R. China.
  • Wang B; Department of Pathology, School of Basic Medical Sciences, Anhui Medical University, Hefei, Anhui, P.R. China.
  • Tao S; Department of Pathology, School of Basic Medical Sciences, Anhui Medical University, Hefei, Anhui, P.R. China.
  • Sun Y; Department of Pathology, School of Basic Medical Sciences, Anhui Medical University, Hefei, Anhui, P.R. China.
  • Ye Q; Department of Pathology, School of Basic Medical Sciences, Anhui Medical University, Hefei, Anhui, P.R. China.
  • Bi X; Department of Pathology, School of Basic Medical Sciences, Anhui Medical University, Hefei, Anhui, P.R. China.
  • Yuan H; Department of Oncology of the First Affiliated Hospital, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, P.R. China.
  • Wu Q; Department of Pathology, School of Basic Medical Sciences, Anhui Medical University, Hefei, Anhui, P.R. China.
  • Lobie PE; Tsinghua-Berkeley Shenzhen Institute and Institute of Biopharmaceutical and Health Engineering, Tsinghua Shenzhen International Graduate School and Shenzhen Bay Laboratory, Shenzhen, Guangdong, P.R. China.
  • Zhu T; Department of Oncology of the First Affiliated Hospital, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, P.R. China.
  • Tan S; Key Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, P.R. China.
  • Huang X; Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, P.R. China.
  • Wu Z; Department of Pathology, School of Basic Medical Sciences, Anhui Medical University, Hefei, Anhui, P.R. China.
Cancer Res ; 82(21): 4001-4015, 2022 11 02.
Article en En | MEDLINE | ID: mdl-36041072
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / MicroARNs Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / MicroARNs Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Año: 2022 Tipo del documento: Article